Andhra Pradesh Gets a Shot in the Arm: Globus Spirits' ₹20 Crore Expansion

Heptachem & Pharma (India) Private Limited is embarking on a transformative journey with the expansion of its Bulk Drugs & Intermediates Project in Isvi, Kurnool, Andhra Pradesh. Scheduled for completion in 2025, this ambitious endeavor will significantly boost the plant's monthly production capacity from 217.52 Tons to an impressive 20 Crores, marking a substantial investment by the company.

One of the most significant aspects of this expansion is its potential to generate employment opportunities in the region. With plans to employ over 200 individuals, Heptachem & Pharma aims to contribute to the economic growth and prosperity of the area.

Moreover, the expansion is expected to yield numerous benefits beyond employment. Economically, it will stimulate the local economy and create a ripple effect of prosperity throughout the community. Industrially, it will fortify India's position as a global leader in bulk drug and intermediate manufacturing, enhancing the country's competitiveness on the international stage.

From a manufacturing standpoint, the expansion will lead to an increased availability of high-quality bulk drugs and intermediates, not only catering to domestic demand but also strengthening India's presence in the global pharmaceutical market.

In a world where access to essential medicines is paramount, Heptachem & Pharma's expansion project promises to make a significant impact. By increasing the availability of bulk drugs and intermediates, it will contribute to making medicines more affordable and accessible to people worldwide, irrespective of their income or location.

Overall, the expansion of Heptachem & Pharma's Bulk Drugs & Intermediates Project in Isvi, Kurnool, Andhra Pradesh is poised to be a resounding success, bringing positive change to the region and propelling the Indian bulk drug and intermediate industry towards greater heights of innovation and accessibility.

News by Rahul Yelligetti